These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32281571)

  • 1. [Postoperative adjuvant chemotherapy for resectable pancreatic cancer].
    Uesaka K
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(4):308-312. PubMed ID: 32281571
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neoadjuvant chemotherapy for resectable pancreatic cancer].
    Unno M
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(4):297-301. PubMed ID: 32281569
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer.
    Keedy VL; Berlin J
    Curr Treat Options Oncol; 2006 Sep; 7(5):381-8. PubMed ID: 16904055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].
    Seufferlein T; Michalski C
    Chirurg; 2022 May; 93(5):441-445. PubMed ID: 35376964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma.
    Du L; DeFoe M; Ruzinova MB; Olsen JR; Wang-Gillam A
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):717-26. PubMed ID: 26226906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant and neoadjuvant therapy for pancreatic cancer.
    Vinciguerra V
    Oncology (Williston Park); 2011 Feb; 25(2):192-3. PubMed ID: 21456392
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hope and frustration of neoadjuvant chemotherapy for resectable pancreatic cancer].
    Lu C; Miao Y; Gao WT
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):813-816. PubMed ID: 30392300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the management of borderline resectable pancreatic cancers.
    Goodman MD; McPartland S; Huber K; Saif MW
    JOP; 2013 Jul; 14(4):334-6. PubMed ID: 23846921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant and neoadjuvant approaches in pancreatic cancer.
    Conroy T; Lambert A; Ducreux M
    Curr Opin Oncol; 2023 Jul; 35(4):326-333. PubMed ID: 37222189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative management of pancreatic cancer.
    Heinemann V; Boeck S
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii273-8. PubMed ID: 18790965
    [No Abstract]   [Full Text] [Related]  

  • 11. Are we ready for neoadjuvant therapy in potentially resectable pancreatic cancer?
    Philip PA
    Oncology (Williston Park); 2011 Feb; 25(2):189-90, 192. PubMed ID: 21456391
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.
    D'Angelo FA; Antolino L; La Rocca M; Petrucciani N; Magistri P; Aurello P; Ramacciato G
    Med Oncol; 2016 Mar; 33(3):28. PubMed ID: 26883935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial.
    Labori KJ; Lassen K; Hoem D; Grønbech JE; Søreide JA; Mortensen K; Smaaland R; Sorbye H; Verbeke C; Dueland S
    BMC Surg; 2017 Aug; 17(1):94. PubMed ID: 28841916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Developments and controversies in neoadjuvant therapy for resectable pancreatic cancer].
    Bai XL; Li X; Liang TB
    Zhonghua Wai Ke Za Zhi; 2020 Jul; 58(7):486-489. PubMed ID: 32610415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neoadjuvant and adjuvant treatment of pancreatic cancer].
    Springfeld C; Hackert T; Jäger D; Büchler MW; Neoptolemos JP
    Chirurg; 2020 Aug; 91(8):636-641. PubMed ID: 32300820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients.
    Olecki EJ; Gusani NJ
    Ann Surg Oncol; 2021 Jun; 28(6):3123. PubMed ID: 33616769
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of adjuvant therapy in the management of pancreatic cancer.
    Laheru D; Yeo CJ
    Adv Surg; 2005; 39():223-44. PubMed ID: 16250554
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Visual Abstract: Adjuvant Chemotherapy with or Without Radiotherapy for Resected Pancreatic Cancer Following Multiagent Neoadjuvant Chemotherapy.
    Franklin O; Sugawara T; Ross RB; Franco SR; Colborn K; Karam S; Schulick RD; Chiaro MD
    Ann Surg Oncol; 2024 Aug; 31(8):4997. PubMed ID: 38671290
    [No Abstract]   [Full Text] [Related]  

  • 20. Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When?
    Kim MP; Katz MHG
    Ann Surg Oncol; 2019 Jun; 26(6):1596-1597. PubMed ID: 30680479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.